Business Issues/Benchmarks

Melt-to-Make Launches New Formula Calculator App to Eliminate Dosing Errors, Streamline Gummy Production

The new digital tool automates batch scaling and cost analysis for cannabis, nutraceutical and functional mushroom manufacturers.

Louisiana Bid for Adult-Use Cannabis Pilot Program Dies; Governor Signs Recriminalization Bill Instead

The state took a turn in 2026 to tighten its cannabis laws rather than loosen them, despite a Schedule III federal posture from the Trump administration.

Aurora Deepens Impact for Veterans Across Canada

The cannabis company’s Strains for Heroes program supports Veteran-focused programs, addressing food security, mental health and community engagement.

5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order

A substance abuse recovery clinic, two doctors, a victims’ advocacy organization and a pharmaceutical company claim the order was unlawful.

Canopy Growth Relaunches Tweed Brand in Germany With New MTL Cannabis Strain Lineup

This marks Canopy’s first international release following its MTL acquisition, as it targets rapid growth in Germany’s medical market.

7 House Democrats Demand IRS, Treasury Provide 280E Cannabis Guidance

The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.

3 US House Republicans Attempt to Thwart Intoxicating Hemp Product Ban

The GOP lawmakers filed three proposed amendments to a federal appropriations bill to modify, delay or stop the ban’s forthcoming implementation.

ATACH Assembles Legal Team to Defend Schedule III, Defeat Prohibitionist Opponents

The American Trade Association for Cannabis and Hemp filed a formal notice to participate in the DEA hearing and retained Shane Pennington of Blank Rome.

SNDL Doesn’t Expect to Close Acquisition of 27 1CM Dispensaries in Ontario

The $27.2-million transaction agreement won’t meet provincial regulatory approvals by the defined date in the acquisition agreement.

3 States Challenge Trump DOJ’s Schedule III Cannabis Rule

Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.

White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

Cresco Labs Marks Historic Step Forward With Medical Cannabis Facility DEA Registrations

The registrations are for the company’s dispensary, cultivation and processing operations.

Page 1 of 544

Next Page